1-3 of 3
Robert Dengler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in the Imatinib-Era: Update on the Survival Outcome Following Allogeneic HSCT after Imatinib Failure; Results of the German CML Study IV

Susanne Saussele, MD, Michael Lauseker, PhD, Martin C. Müller, MD, Alois Gratwohl, Dietrich Beelen, MD, Donald W. Bunjes, MD, Rainer Schwerdtfeger, MD, Hans-Jochem Kolb, MD, Anthony D Ho, MD, Christiane Falge, MD, Ernst Holler, PhD, Günther Schlimok, MD, Axel R. Zander, MD, Renate Arnold, MD, Lothar Kanz, MD, Robert Dengler, MD, Claudia Haferlach, MD, Brigitte Schlegelberger, MD, Susanne Schnittger, PhD, Lida Kalmanti, MD, Ulrike Proetel, MD, Benjamin Hanfstein, MD, Wolf-Karsten Hofmann, Joerg Hasford, MD, Andreas Hochhaus, MD, Markus Pfirrmann, PhD, Rüdiger Hehlmann, MD
Journal: Blood
Blood (2014) 124 (21): 2567.
https://doi.org/10.1182/blood.V124.21.2567.2567
Published: 2014
Journal Articles

Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV

Clinical Trials & Observations
Susanne Saussele, Michael Lauseker, Alois Gratwohl, Dietrich W. Beelen, Donald Bunjes, Rainer Schwerdtfeger, Hans-Jochem Kolb, Anthony D. Ho, Christiane Falge, Ernst Holler, Günter Schlimok, Axel R. Zander, Renate Arnold, Lothar Kanz, Robert Dengler, Claudia Haferlach, Brigitte Schlegelberger, Markus Pfirrmann, Martin C. Müller, Susanne Schnittger, Armin Leitner, Nadine Pletsch, Andreas Hochhaus, Joerg Hasford, Rüdiger Hehlmann, for the German CML Study Group
Journal: Blood
Blood (2010) 115 (10): 1880–1885.
https://doi.org/10.1182/blood-2009-08-237115
Published: 2010
Includes: Supplemental data
Journal Articles

Detection of Three Different MPLW515 Mutations in 10.1% of All JAK2 V617 Unmutated ET and 9.3% of All JAK2 V617F Unmutated OMF: A Study of 387 Patients.

Susanne Schnittger, PhD, Claudia Haferlach, MD, Dietrich W. Beelen, MD, Peter Bojko, MD, Robert Dengler, MD, Andrea Diestelrath, MD, M.J. Eckart, MD, Robert Eckert, MD, Stefan Fries, MD, Georg Köchling, MD, Hans P. Laubenstein, MD, Manfred Planker, MD, Rudolf Pihusch, MD, Wolfgang Kern, MD, Torsten Haferlach, MD
Journal: Blood
Blood (2007) 110 (11): 2546.
https://doi.org/10.1182/blood.V110.11.2546.2546
Published: 2007